Srs Capital Advisors, Inc. Neurocrine Biosciences Inc Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 534 shares of NBIX stock, worth $80,372. This represents 0.0% of its overall portfolio holdings.
Number of Shares
534
Previous 782
31.71%
Holding current value
$80,372
Previous $90,000
20.0%
% of portfolio
0.0%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding NBIX
# of Institutions
642Shares Held
94.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.14 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.5 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$775 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$387 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$281 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...